Ginsennoside Rd Attenuates Cognitive Dysfunction in a Rat Model of Alzheimer’s Disease

详细信息    查看全文

• 作者：Juanfang Liu (1)
  Xiaodong Yan (2)
  Ling Li (1)
  Yi Zhu (1)
  Kefeng Qin (3)
  Linfu Zhou (4)
  Dong Sun (1)
  Xiaohui Zhang (5)
  Ruidong Ye (1)
  Gang Zhao (1)
  
• 关键词：Ginsennoside Rd ; Alzheimer’s disease ; Cognition ; Apoptosis ; Inflammatory reaction
• 刊名：Neurochemical Research
• 出版年：2012
• 出版时间：December 2012
• 年：2012
• 卷：37
• 期：12
• 页码：2738-2747
• 全文大小：976KB
• 参考文献：1. Hu SY (1977) A contribution to our knowledge of ginseng. Am J Chin Med (Gard City NY) 5:1-3 CrossRef
  2. Yokozawa T, Satoh A, Cho EJ (2004) Ginsenoside-Rd attenuates oxidative damage related to aging in senescence-accelerated mice. J Pharm Pharmacol 56:107-13 CrossRef
  3. Yokozawa T, Liu ZW, Dong E (1998) A study of ginsenoside-Rd in a renal ischemia-reperfusion model. Nephron 78:201-06 CrossRef
  4. Yokozawa T, Owada S (1999) Effect of ginsenoside-Rd in cephaloridine-induced renal disorder. Nephron 81:200-07 CrossRef
  5. Lopez MV, Cuadrado MP, Ruiz-Poveda OM, Del Fresno AM, Accame ME (2007) Neuroprotective effect of individual ginsenosides on astrocytes primary culture. Biochim Biophys Acta 1770:1308-316 CrossRef
  6. Tamura T, Cui X, Sakaguchi N, Akashi M (2008) Ginsenoside Rd prevents and rescues rat intestinal epithelial cells from irradiation-induced apoptosis. Food Chem Toxicol 46:3080-089 CrossRef
  7. Li XY, Liang J, Tang YB, Zhou JG, Guan YY (2010) Ginsenoside Rd prevents glutamate-induced apoptosis in rat cortical neurons. Clin Exp Pharmacol Physiol 37:199-04 CrossRef
  8. Lin WM, Zhang YM, Moldzio R, Rausch WD (2007) Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture. J Neural Transm Suppl 72:105-12 CrossRef
  9. Wu CF, Bi XL, Yang JY, Zhan JY, Dong YX, Wang JH, Wang JM, Zhang R, Li X (2007) Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia. Int Immunopharmacol 7:313-20 CrossRef
  10. Barber R (2011) Inflammatory signaling in Alzheimer disease and depression. Cleve Clin J Med 78(Suppl 1):S47–S49 CrossRef
  11. Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, Garcia-Quintanilla A, Cano J, Brundin P, Englund E, Venero JL, Joseph B (2011) Caspase signalling controls microglia activation and neurotoxicity. Nature 472:319-24 CrossRef
  12. Stephan A, Laroche S, Davis S (2001) Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci 21:5703-714
  13. Yan JJ, Cho JY, Kim HS, Kim KL, Jung JS, Huh SO, Suh HW, Kim YH, Song DK (2001) Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 133:89-6 CrossRef
  14. Peirson SN, Butler JN, Foster RG (2003) Experimental validation of novel and conventional approaches to qPCR data analysis. Nucleic Acids Res 31:e73 CrossRef
  15. Yan XD, Liu JF, Luo ZP, Ding QX, Mao XG, Yan M, Yang SG, Hu XY, Huang JH, Luo ZJ (2010) Proteomic profiling of proteins in rat spinal cord induced by contusion injury. Neurochem Int 56:971-83 CrossRef
  16. Linkov F, Ferris RL, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Gooding W, Nolan B, Winans M, Siegel ER, Lokshin A, Stack BC Jr (2008) Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases. Proteomics Clin Appl 2:1575-585 CrossRef
  17. DuPont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL (2005) Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 66:175-91 CrossRef
  18. Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214-26 CrossRef
  19. Tseng YC, Chen RD, Lucassen M, Schmidt MM, Dringen R (2011) Exploring uncoupling proteins and antioxidant mechanisms under acute cold exposure in brains of fish. PLoS ONE 6:e18180 CrossRef
  20. Roh MI, Murakami Y, Thanos A, Vavvas DG, Miller JW (2011) Edaravone, an ROS scavenger, ameliorates photoreceptor cell death after experimental retinal detachment. Invest Ophthalmol Vis Sci 52:3825-831 CrossRef
  21. Greenberg BD, Savage MJ, Howland DS, Ali SM, Siedlak SL, Perry G, Siman R, Scott RW (1996) APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology. Neurobiol Aging 17:153-71 CrossRef
  22. Nitta A, Fukuta T, Hasegawa T, Nabeshima T (1997) Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn J Pharmacol 73:51-7 CrossRef
  23. Bons N, Mestre N, Ritchie K, Petter A, Podlisny M, Selkoe D (1994) Identification of amyloid beta protein in the brain of the small, short-lived lemurian primate Microcebus murinus. Neurobiol Aging 15:215-20 CrossRef
  24. Itoh A, Nitta A, Nadai M, Nishimura K, Hirose M, Hasegawa T, Nabeshima T (1996) Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein–infused rats. J Neurochem 66:1113-117 CrossRef
  25. Xuan NT, Shumilina E, Kempe DS, Gulbins E, Lang F (2010) Sphingomyelinase dependent apoptosis of dendritic cells following treatment with amyloid peptides. J Neuroimmunol 219:81-9 CrossRef
  26. Wirths O, Breyhan H, Marcello A, Cotel MC, Bruck W, Bayer TA (2010) Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer’s disease. Neurobiol Aging 31:747-57 CrossRef
  27. Hensley K (2010) Neuroinflammation in Alzheimer’s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J Alzheimers Dis 21:1-4
  28. Craft JM, Watterson DM, Van Eldik LJ (2006) Human amyloid beta-induced neuroinflammation is an early event in neurodegeneration. Glia 53:484-90 CrossRef
  29. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O’Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer’s disease. Neurobiol Aging 21:383-21 CrossRef
  30. Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12:1005-015
  31. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J (2003) Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9:453-57 CrossRef
  32. Rossner S, Lange-Dohna C, Zeitschel U, Perez-Polo JR (2005) Alzheimer’s disease beta-secretase BACE1 is not a neuron-specific enzyme. J Neurochem 92:226-34 CrossRef
  33. Sastre M, Klockgether T, Heneka MT (2006) Contribution of inflammatory processes to Alzheimer’s disease: molecular mechanisms. Int J Dev Neurosci 24:167-76 CrossRef
  34. Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC (2004) Contribution of glial cells to the development of amyloid plaques in Alzheimer’s disease. Neurobiol Aging 25:663-74 CrossRef
  35. Folch J, Alvira D, Lopez-Querol M, Tajes M, Sureda FX, Forsby A, Rimbau V, Camins A, Pallas M (2010) Evaluation of transcriptional activity of caspase-3 gene as a marker of acute neurotoxicity in rat cerebellar granular cells. Toxicol In Vitro 24:465-71 CrossRef
  36. Li Z, Jo J, Jia JM, Lo SC, Whitcomb DJ, Jiao S, Cho K, Sheng M (2010) Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 141:859-71 CrossRef
  37. Kang HJ, Yoon WJ, Moon GJ, Kim DY, Sohn S, Kwon HJ, Gwag BJ (2005) Caspase-3-mediated cleavage of PHF-1 tau during apoptosis irrespective of excitotoxicity and oxidative stress: an implication to Alzheimer’s disease. Neurobiol Dis 18:450-58 CrossRef
  38. Yan X, Xiao R, Dou Y, Wang S, Qiao Z, Qiao J (2000) Carbachol blocks beta-amyloid fragment 31-5-induced apoptosis in cultured cortical neurons. Brain Res Bull 51:465-70 CrossRef
  
• 作者单位：Juanfang Liu (1)
  Xiaodong Yan (2)
  Ling Li (1)
  Yi Zhu (1)
  Kefeng Qin (3)
  Linfu Zhou (4)
  Dong Sun (1)
  Xiaohui Zhang (5)
  Ruidong Ye (1)
  Gang Zhao (1)
  
  1. Department of Neurology, Xijing Hospital, Fourth Military Medical University, 127 West Changle Road, Xi’an, 710032, People’s Republic of China
  2. Department of Orthopaedics, Tangdu Hospital, Fourth Military Medical University, Xi’an, People’s Republic of China
  3. Department of Neurology, University of Chicago, Chicago, IL, USA
  4. Department of Neurology, The Third Hospital of PLA, Baoji, People’s Republic of China
  5. Division of Neurology, Department of Internal Medicine, Dalian Sanatorium, Shenyang Military Region, Dalian, People’s Republic of China
  
• ISSN：1573-6903

文摘

Alzheimer’s disease is a neurodegenerative disease characterized by the production of β-amyloid proteins and hyperphosphorylation of tau protein. Inflammation and apoptotic severity were highly correlated with earlier age at onset of Alzheimer’s disease and were also associated with cognitive decline. This study aims to examine whether the traditional Chinese medicine ginsennoside Rd could prevent cognitive deficit and take neuroprotective effects in β-amyloid peptide 1-0-induced rat model of Alzheimer’s disease. To produce Alzheimer’s disease animal model, aggregated β-amyloid peptide 1-0 injected into hippocampus bilaterally. Ginsennoside Rd protected their cognitive impairment and improved their memory function by daily intraperitoneal injection for 30?days consecutively. In addition, ginsennoside Rd alleviated the inflammation induced by β-amyloid peptide 1-0. Furthermore, ginsennoside Rd played a role in the down-regulation of caspase-3 proteins and reduced the apoptosis that normally followed β-amyloid peptide 1-0 injection. The results of this study showed that the pretreatment of ginsennoside Rd had neuroprotective effects in β-amyloid peptide 1-0-induced AD model rat.